177,598 Scholar Rock Holding Corporation $SRRK Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC lowered its holdings in Scholar Rock Holding Corporation (NASDAQ:SRRK – Free Report) by 40.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 261,849 shares of the company’s stock after selling 177,598 shares during the quarter. Fisher Asset Management LLC’s holdings in Scholar Rock were worth $12,653,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of SRRK. GAMMA Investing LLC lifted its position in shares of Scholar Rock by 20.8% in the 2nd quarter. GAMMA Investing LLC now owns 1,406 shares of the company’s stock worth $77,000 after purchasing an additional 242 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Scholar Rock by 28.1% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,618 shares of the company’s stock worth $127,000 after buying an additional 574 shares during the last quarter. Syon Capital LLC grew its position in shares of Scholar Rock by 6.4% in the 2nd quarter. Syon Capital LLC now owns 9,782 shares of the company’s stock worth $538,000 after buying an additional 588 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Scholar Rock by 92.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,270 shares of the company’s stock worth $62,000 after acquiring an additional 610 shares in the last quarter. Finally, Allworth Financial LP bought a new position in shares of Scholar Rock during the 2nd quarter worth approximately $35,000. Institutional investors own 91.08% of the company’s stock.

Scholar Rock Price Performance

NASDAQ:SRRK opened at $43.21 on Monday. The firm’s fifty day moving average is $46.13 and its two-hundred day moving average is $48.22. The firm has a market cap of $5.27 billion, a price-to-earnings ratio of -12.86 and a beta of 0.78. The company has a debt-to-equity ratio of 1.16, a quick ratio of 5.40 and a current ratio of 5.41. Scholar Rock Holding Corporation has a one year low of $34.25 and a one year high of $61.76.

Scholar Rock (NASDAQ:SRRK – Get Free Report) last issued its earnings results on Tuesday, November 10th. The company reported ($0.81) EPS for the quarter, topping analysts’ consensus estimates of ($0.85) by $0.04. The company had revenue of $0.57 million during the quarter, compared to analysts’ expectations of $0.30 million. During the same quarter in the previous year, the company earned ($0.90) EPS. Research analysts expect that Scholar Rock Holding Corporation will post -3.04 EPS for the current year.

More Scholar Rock News

Investors following SRRK have been watching these news items:

  • Positive Sentiment: HC Wainwright raised its Q4 2026 EPS estimate to a loss of $0.75 from $0.78 and its FY2026 estimate to a loss of $3.23 from $3.30. The firm maintained its Buy rating and $70 price target. HC Wainwright Predicts Scholar Rock Q1 Earnings
  • Negative Sentiment: Wolfe Research downgraded SRRK from Outperform to Peer Perform, removing a bullish rating signal. Wolfe Research ratings
  • Negative Sentiment: HC Wainwright cut estimates for FY2027–FY2030: its FY2029 forecast shifted from $0.47 in earnings per share to a $0.12 loss, while its FY2030 forecast fell from $1.44 to $1.00. These longer-range cuts temper the improved near-term outlook. Scholar Rock analyst estimates

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on SRRK shares. Citigroup increased their target price on shares of Scholar Rock from $60.00 to $74.00 and gave the company a “buy” rating in a research report on Monday, September 14th. TD Cowen reaffirmed a “buy” rating on shares of Scholar Rock in a report on Monday, September 14th. Evercore reaffirmed an “outperform” rating and set a $72.00 price target on shares of Scholar Rock in a research report on Tuesday, September 15th. Barclays lowered Scholar Rock from an “overweight” rating to a “cautious” rating in a report on Tuesday, September 15th. Finally, UBS Group reiterated a “buy” rating on shares of Scholar Rock in a report on Tuesday, September 15th. Three investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $67.67.

View Our Latest Stock Analysis on Scholar Rock

Insider Activity at Scholar Rock

In other Scholar Rock news, Director Srinivas Akkaraju purchased 146,970 shares of Scholar Rock stock in a transaction that occurred on Monday, October 26th. The stock was bought at an average price of $41.59 per share, with a total value of $6,112,482.30. Following the acquisition, the director owned 6,380,517 shares of the company’s stock, valued at $265,365,702.03. This trade represents a 2.36% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 10.30% of the stock is owned by company insiders.

Scholar Rock Company Profile

(Free Report)

Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-β) superfamily, which plays roles in processes including muscle development and immune regulation. The company’s lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients’ motor function.

Further Reading

Want to see what other hedge funds are holding SRRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Scholar Rock Holding Corporation (NASDAQ:SRRK – Free Report).

Institutional Ownership by Quarter for Scholar Rock (NASDAQ:SRRK)

Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.